New drug delivers promising survival gains in pancreatic cancer
About 90% of people with pancreatic cancer have pancreatic ductal adenocarcinoma (PDAC), which is driven by an activating mutation in…
Study reveals sex-based protein differences across lung cancer types
Biological sex factors into cancer in ways you might not expect. In lung cancer, a form called squamous…
Microbiome science merges with oncology for better cancer treatments
Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to…
Adult weight gain strongly linked to higher obesity-related cancer risk
New research presented at this year’s European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows…
Six genes found to connect pancreatic cancer with metabolic dysfunction
New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain…
AI model detects pancreatic cancer years before clinical diagnosis
An AI model (REDMOD) can pick up the very early subtle tissue changes of pancreatic ductal adenocarcinoma, the…
Clusterin inhibition offers new hope for treating cervical gastric-type adenocarcinoma
Gastric-type adenocarcinoma (GAS) is one of the most aggressive non-human papillomavirus (HPV)-associated cervical adenocarcinomas and remains especially difficult…
Metabolic pathways drive progression from pancreatic lesions to cancer
Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate.…
Detailed cell atlas reveals earliest changes in prostate cancer
Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now,…
Rising lung cancer in never smokers demands urgent research focus
Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer…
Dual targeting strategy suppresses pancreatic cancer cell growth
A new research paper was published in Volume 13 of Oncoscience on January 28, 2026, titled “Dual targeting of oncogenic microtubules…
CTDNEP1 identified as potential tumor suppressor in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining…